A study also indicates that FOXA3 is deregulated in lung cancer and that high FOXA3 expression is linked to adverse overall survival, suggesting FOXA3 can serve as a prognostic biomarker for lung cancer patients [37]. This evidence concerns the gene FOXA3 and lung carcinoma.